Holen Sie sich die Stockscreener-App
13.14
0.08%
-0.010
Handel nachbörslich:
12.92
-0.22
-1.67%
Schlusskurs vom Vortag:
$13.15
Offen:
$13.25
24-Stunden-Volumen:
102.46K
Relative Volume:
1.67
Marktkapitalisierung:
$266.00M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-0.4386
EPS:
-29.96
Netto-Cashflow:
-
1W Leistung:
+0.61%
1M Leistung:
+942.94%
6M Leistung:
+942.94%
1J Leistung:
+942.94%
1-Tages-Spanne:
$12.58
$13.41
1-Wochen-Bereich:
$11.75
$13.41
52-Wochen-Spanne:
$11.75
$17.94
Shoulder Innovations Inc Stock (SI) Company Profile
Firmenname
Shoulder Innovations Inc
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie SI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SI
Shoulder Innovations Inc
|
13.14 | 266.00M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
129.40 | 228.03B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.50 | 152.09B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
378.95 | 143.98B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.91 | 117.98B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.68 | 45.17B | 5.69B | 1.41B | 577.90M | 6.95 |
Shoulder Innovations Inc Stock (SI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-03-06 | Herabstufung | Compass Point | Neutral → Sell |
| 2023-03-06 | Herabstufung | Wedbush | Neutral → Underperform |
| 2023-03-02 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-03-02 | Herabstufung | Compass Point | Buy → Neutral |
| 2023-03-02 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-03-01 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2023-01-09 | Herabstufung | Wedbush | Outperform → Neutral |
| 2023-01-06 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-06 | Herabstufung | Craig Hallum | Buy → Hold |
| 2023-01-06 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-12 | Bestätigt | Wedbush | Outperform |
| 2022-12-05 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-11-21 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-11-10 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-10-26 | Herabstufung | Goldman | Buy → Neutral |
| 2022-10-06 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2022-08-04 | Eingeleitet | BTIG Research | Buy |
| 2022-06-13 | Eingeleitet | Wells Fargo | Overweight |
| 2022-06-09 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-03-21 | Eingeleitet | BofA Securities | Buy |
| 2022-01-20 | Hochstufung | Goldman | Neutral → Buy |
| 2021-12-16 | Eingeleitet | B. Riley Securities | Buy |
| 2021-11-11 | Eingeleitet | JP Morgan | Overweight |
| 2021-11-08 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-09-27 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-06-14 | Eingeleitet | Goldman | Neutral |
| 2021-01-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-12-22 | Eingeleitet | Wedbush | Outperform |
| 2020-12-17 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-12-02 | Eingeleitet | Craig Hallum | Buy |
| 2020-10-16 | Eingeleitet | Compass Point | Buy |
| 2020-03-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | Keefe Bruyette | Mkt Perform |
| 2019-12-02 | Eingeleitet | Barclays | Overweight |
| 2019-11-18 | Eingeleitet | Compass Point | Buy |
Alle ansehen
Shoulder Innovations Inc Aktie (SI) Neueste Nachrichten
Shoulder Innovations Expands Surgical Solutions with NYSE Listing—Global Brain Invests - thebridge.jp
Med-tech funding rebounds modestly to $18B through July - BioWorld MedTech
Medical Tech Firm Heartflow Jumps 51% After $317 Million IPO - Bloomberg.com
Medical Tech Firm Heartflow Surges 66% After $317 Million IPO - Bloomberg.com
Heartflow raises USD 317M in IPO - Medical Buyer
Medical Tech Firm Heartflow Prices $317 Million IPO Above Range - Bloomberg.com
Shoulder Innovations Stock Jumps 8% On NYSE Debut - MSN
Medical Tech Firm Heartflow Raises IPO Target to $300 Million - Bloomberg.com
Gilde healthcare buys $1.5 million in shoulder innovations (SI) By Investing.com - Investing.com Australia
Gilde healthcare buys $1.5 million in shoulder innovations (SI) - Investing.com
U.S. IPO Weekly Recap: Figma Smashes Circle’s Record For Best Billion-Dollar IPO Pop - Seeking Alpha
Heartflow prices IPO, Shoulder Innovation joins NYSE - BioWorld MedTech
Shoulder Innovations: Interesting, Not Convinced (NYSE:SI) - Seeking Alpha
Shoulder Innovations falls short of IPO target with $75M raise - Crain's Grand Rapids Business
NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO - The Malaysian Reserve
Latham & Watkins Advises Shoulder Innovations in Initial Public Offering - Latham & Watkins LLP
Shoulder Innovations announces pricing of IPO - Medical Buyer
Figma Surges in IPO, Valued at Over $19 Billion - AInvest
NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO – Company Announcement - Financial Times
Shoulder Innovations Announces Pricing of Initial Public Offering - PR Newswire
Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival - MSN
Shoulder Innovations is an IPO to watch, this analyst says - Cantech Letter
Grand Rapids device maker plans $105M IPO as implant sales surge - Crain's Grand Rapids Business
Del. Judge Denies $89M Claim In Silvergate Ch. 11 - Law360
US Life Sciences IPOs Revive with Medtech Companies Leading the Way - AInvest
Shoulder Innovations, Inc. (SI): Small MedTech Implant Company Gaining IPO Interest - Smartkarma
These innovations are transforming shoulder replacement surgery for optimal recovery. - thegazette.com
SHOULDER INNOVATIONS, INC. Plans $100 Million IPO for July 31st (SI) - Defense World
Pro Deals: 👩⚕️ Health Tech weekly - Axios
Shoulder Innovations Primes $100M IPO Amid Medtech Surge - Law360
Shoulder Innovations, Inc. (SI): Another MedTech to Test the Market, Sets Terms for July 31 IPO - Smartkarma
Shoulder Innovations Seeks $105M in U.S. IPO, Revenue Up 40% - AInvest
Shoulder Innovations Files for 5M Share IPO at $19-$21/sh - Investing.com Canada
Shoulder Innovations Announces Closing of a $40 Million Convertible Notes Financing - PR Newswire
Shoulder Innovations IPO Preview: Seeing Value In InSet Glenoid Technology and Disruptive Ecosystem - Smartkarma
Silvergate Capital (NYSE:SI) Trading Up 25% – Still a Buy? - Defense World
SEC Charges Alan Lane & Kathleen Fraher - stl.news
U.S. IPO Weekly Recap: 6 Small Listings Hit Market As Sizable IPOs Join The Pipeline - Seeking Alpha
Shoulder Innovations Begins IPO Effort For Commercialization Plans (Pending:SI) - Seeking Alpha
Cohen Milstein Sellers & Toll PLLC and Bernstein Litowitz Berger & Grossmann LLP Announce Pendency and Proposed Settlement of Class Action Involving All Persons and Entities who Purchased or Otherwise Acquired the Publicly Traded Common Stock a - ETX View
Venture-Backed MedTech Firm Shoulder Innovations Files IPO - Law360
SI IPO NewsShoulder surgery-focused medtech Shoulder Innovations files for a $100 million IPO - renaissancecapital.com
Silvergate Announces Virtual Participation at Canaccord’s 40th Annual Growth Conference - Business Wire
Bioretec Oy's Oversubscribed Rights Issue Fuels Ambitious Growth in Orthopedic Innovations - AInvest
Silvergate Capital $37.5M Securities Class Action Settlement - Claim Depot
Head to Head Contrast: Silvergate Capital (NYSE:SI) and RBB Bancorp (NASDAQ:RBB) - Defense World
Fed board issues order to Silvergate Bank as part of self-liquidation plan - PANews
Silvergate Estate To Chip In For $37.5M Investor Settlement - Law360
Head-To-Head Survey: Silvergate Capital (NYSE:SI) & Citizens & Northern (NASDAQ:CZNC) - Defense World
Variability in ultimate humeral height of an inlay humeral stem does not impact outcomes following reverse shoulder arthroplasty - ScienceDirect.com
Silvergate Gets Pause To Examiner Fight After Investor Deal - Law360
Finanzdaten der Shoulder Innovations Inc-Aktie (SI)
Es liegen keine Finanzdaten für Shoulder Innovations Inc (SI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.31%
1.36%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):